APVO vs MA · rev $3.1M vs P/E 38, rev $17.68B
Aptevo Therapeutics Inc (APVO) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
APVO currently screens at market cap $9.9M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the APVO and MA stock pages for the full models.
Not investment advice.